Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test

Autor: Mahoko Furujo, Motoharu Ochi, Yousuke Higuchi, Takahiro Namba, Yuki Ebuchi, Hiroki Tsuchiya, Shoko Fujinaga, Naoko Urata, Toshihide Kubo, Michiko Kishi, Narumi Hara
Rok vydání: 2020
Předmět:
Male
endocrine system
medicine.medical_specialty
Time Factors
Adolescent
Hormone Replacement Therapy
Endocrinology
Diabetes and Metabolism

Thyroid Gland
Levothyroxine
Thyrotropin-releasing hormone
030209 endocrinology & metabolism
Thyroid Function Tests
Growth hormone deficiency
03 medical and health sciences
0302 clinical medicine
Endocrinology
TRH stimulation test
Hypothyroidism
Japan
Predictive Value of Tests
Internal medicine
Central hypothyroidism
medicine
Humans
Child
Thyrotropin-Releasing Hormone
Growth Disorders
Retrospective Studies
Human Growth Hormone
business.industry
Infant
Newborn

medicine.disease
Thyroid Diseases
Child
Preschool

Infant
Small for Gestational Age

Pediatrics
Perinatology and Child Health

IGHD
Female
Thyroid function
business
hormones
hormone substitutes
and hormone antagonists

Follow-Up Studies
030215 immunology
medicine.drug
Hormone
Zdroj: Journal of Pediatric Endocrinology and Metabolism. 33:1417-1423
ISSN: 2191-0251
0334-018X
Popis: Background The relationship between growth hormone (GH)-replacement therapy and the thyroid axis in GH-deficient (GHD) children remains controversial. Furthermore, there have been few reports regarding non-GHD children. We aimed to determine the effect of GH therapy on thyroid function in GHD and non-GHD children and to assess whether thyrotropin-releasing hormone (TRH) stimulation test is helpful for the identification of central hypothyroidism before GH therapy. Methods We retrospectively analyzed data from patients that started GH therapy between 2005 and 2015. The free thyroxine (FT4) and thyroid-stimulating hormone (TSH) concentrations were measured before and during 24 months of GH therapy. The participants were 149 children appropriate for gestational age with GHD (IGHD: isolated GHD) (group 1), 29 small for gestational age (SGA) children with GHD (group 2), and 25 short SGA children (group 3). Results In groups 1 and 2, but not in group 3, serum FT4 concentration transiently decreased. Two IGHD participants exhibited central hypothyroidism during GH therapy, and required levothyroxine (LT4) replacement. They showed either delayed and/or prolonged responses to TRH stimulation tests before start of GH therapy. Conclusions GH therapy had little pharmacological effect on thyroid function, similar changes in serum FT4 concentrations were not observed in participants with SGA but not GHD cases who were administered GH at a pharmacological dose. However, two IGHD participants showed central hypothyroidism and needed LT4 replacement therapy during GH therapy. TRH stimulation test before GH therapy could identify such patients and provoke careful follow-up evaluation of serum FT4 and TSH concentrations.
Databáze: OpenAIRE